David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$751M |
| 2 |
Advanced Micro Devices
AMD
|
+$751M |
| 3 |
Micron Technology
MU
|
+$426M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$363M |
| 5 |
ExxonMobil
XOM
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$546M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$485M |
| 3 |
VMW
VMware, Inc
VMW
|
+$393M |
| 4 |
Microsoft
MSFT
|
+$336M |
| 5 |
UnitedHealth
UNH
|
+$303M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.03% |
| 2 | Consumer Discretionary | 9.51% |
| 3 | Healthcare | 5.77% |
| 4 | Financials | 5.47% |
| 5 | Communication Services | 4.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3501
Blink Charging
BLNK
$84.7M
| $379K | ﹤0.01% |
+111,766
| New | +$349K |
|
3502
Ooma
OOMA
$584M
| $379K | ﹤0.01% |
35,305
-5,778
| -14% | -$65.6K |
|
3503
Rocky Brands
RCKY
$344M
| $378K | ﹤0.01% |
+12,536
| New | +$277K |
|
|
NXDR
3504
Nextdoor Holdings
NXDR
$917M
| $378K | ﹤0.01% |
199,859
+18,983
| +10% | +$33.5K |
|
3505
Alpha and Omega Semiconductor
AOSL
$783M
| $378K | ﹤0.01% |
+14,489
| New | +$358K |
|
3506
Eve Holding Inc Warrants
EVEX.WS
$30.3M
| $377K | ﹤0.01% |
384,473
+63,593
| +20% | +$44.9K |
|
3507
Royalty Pharma
RPRX
$27.3B
| $376K | ﹤0.01% |
13,387
-384,459
| -97% | -$10.6M |
|
3508
iShares MSCI USA Min Vol Factor ETF
USMV
$24.4B
| $376K | ﹤0.01% |
+4,819
| New | +$360K |
|
|
RNAM
3509
DELISTED
Avidity Biosciences
RNAM
| $375K | ﹤0.01% |
41,486
-111,793
| -73% | -$747K |
|
3510
Horizon Technology Finance
HRZN
$326M
| $375K | ﹤0.01% |
+28,461
| New | +$348K |
|
3511
Ameresco
AMRC
$1.11B
| $375K | ﹤0.01% |
+11,835
| New | +$357K |
|
|
ICVX
3512
DELISTED
Icosavax, Inc. Common Stock
ICVX
| $374K | ﹤0.01% |
+23,715
| New | +$228K |
|
3513
Skyworks Solutions
SWKS
$10.1B
| $371K | ﹤0.01% |
3,300
-47,819
| -94% | -$4.68M |
|
|
CFB
3514
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $369K | ﹤0.01% |
27,152
+10,545
| +63% | +$121K |
|
|
HA
3515
DELISTED
Hawaiian Holdings, Inc.
HA
| $368K | ﹤0.01% |
25,937
-35
| -0.1% | -$260 |
|
3516
PTC
PTC
$16.7B
| $365K | ﹤0.01% |
2,086
-4,522
| -68% | -$694K |
|
3517
CDW
CDW
$16.6B
| $364K | ﹤0.01% |
1,600
-2,941
| -65% | -$623K |
|
3518
RPC Inc
RES
$1.37B
| $363K | ﹤0.01% |
49,917
-173,161
| -78% | -$1.36M |
|
3519
Banco de Chile
BCH
$21.7B
| $362K | ﹤0.01% |
15,682
+5,035
| +47% | +$107K |
|
3520
Saratoga Investment
SAR
$297M
| $362K | ﹤0.01% |
+13,996
| New | +$350K |
|
|
LILM
3521
DELISTED
Lilium N.V. Class A Ordinary Shares
LILM
| $362K | ﹤0.01% |
306,679
+24,349
| +9% | +$22.2K |
|
3522
Oppenheimer Holdings
OPY
$1.24B
| $360K | ﹤0.01% |
+8,705
| New | +$333K |
|
3523
Evercore
EVR
$11.2B
| $360K | ﹤0.01% |
2,102
+602
| +40% | +$87.2K |
|
|
GOOS
3524
Canada Goose Holdings
GOOS
$809M
| $359K | ﹤0.01% |
30,262
-103,849
| -77% | -$1.23M |
|
|
MAXN
3525
PUT
DELISTED
Maxeon Solar Technologies
MAXN
| $359K | ﹤0.01% |
+501
| New | +$327K |
|
Similar funds
David Shaw's Q4 2023 Portfolio in Review
As of Q4 2023, David Shaw held 4,806 positions worth $114B, up 19% from $95.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
David Shaw's Q4 2023 filing shows 575 new, 1,549 increased, 1,464 reduced and 527 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $546M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q4 2023 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M.
- David Shaw added most to Netflix in Q4 2023, an estimated $751M increase.
- David Shaw's biggest Q4 2023 reduction was Microsoft, cutting an estimated $336M.
- David Shaw fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $546M.
- David Shaw's ten largest holdings make up 12% of its $114B portfolio in Q4 2023.
- David Shaw opened 575 new positions and closed 527 in Q4 2023.
- David Shaw's portfolio value rose 19% quarter-over-quarter to $114B.
Based on D.E. Shaw & Co's 13F filing for Q4 2023, filed 14 Feb 2024.